Template:Anderson2016 table2: Difference between revisions
From Embryology
m (Protected "Template:Anderson2016 table2" ([Edit=Allow only administrators] (indefinite) [Move=Allow only administrators] (indefinite))) |
mNo edit summary |
||
| Line 1: | Line 1: | ||
{| | {| | ||
|+ colspan=3|'''Table 2. Summary of Timing (Post Fertilization) of Susceptibility to a Drug-Induced Malformation''' | |||
|-bgcolor="CEDFF2" | |-bgcolor="CEDFF2" | ||
! width=300px|Lesion | ! width=300px|Lesion | ||
| Line 118: | Line 118: | ||
! colspan=3|Notes | ! colspan=3|Notes | ||
|- | |- | ||
| colspan=3|For approximate clinical Gestational Age {{GA}} add 2 weeks; number in brackets is mouse equivalent. | | colspan=3|For approximate clinical Gestational Age {{GA}} add 2 weeks; number in brackets is mouse equivalent. Data Reference<ref name=Anderson2016>{{Ref-Anderson2016}}</ref> | ||
| colspan=3|'''Links:''' {{heart}} | {{abnormal development}} | {{timeline}} | [[:Category:Timeline]] | |||
Reference | |||
|}<noinclude>[[Category:Heart]][[Category:Abnormal Development]][[Category:Table]][[Category:Timeline]]</noinclude> | |}<noinclude>[[Category:Heart]][[Category:Abnormal Development]][[Category:Table]][[Category:Timeline]]</noinclude> | ||
{{Anderson2016 collapsetable2}} | {{Anderson2016 collapsetable2}} | ||
Latest revision as of 16:00, 11 Mayıs 2018
| Lesion | Start of Susceptibility to Malformation |
End of Susceptibility to Malformation | |||
|---|---|---|---|---|---|
| Interatrial communications | |||||
| Oval fossa defect | 6 weeks (E13.5) | Term | |||
| Sinus venosus defect | 8 weeks | 12 weeks | |||
| Coronary sinus defect | 8 weeks | Term | |||
| Vestibular defect | 7 weeks | 8 weeks | |||
| Ventricular Septal Defect | |||||
| Muscular | 8 weeks | Difficult to predict | |||
| Perimembranous | 6 weeks | 8 weeks | |||
| Doubly committed | 7 weeks | 8 weeks | |||
| Atrioventricular Septal Defect | |||||
| Ostium primum | 5 weeks | 6 weeks | |||
| “Complete” | 5 weeks | 6 weeks | |||
| Aortic coarctation | |||||
| With VSD | 5 weeks | 8 weeks | |||
| With intact ventricular septum | 8 weeks | Term | |||
| Double Outlet Right Ventricle | 6 weeks | 8 weeks | |||
| Transposition of Great Arteries | 6 weeks | 8 weeks | |||
| Ebstein’s malformation | 6 weeks | 8 weeks | |||
| Hypoplastic left heart syndrome | |||||
| With mitral atresia | 5 weeks | 8 weeks | |||
| With mitral stenosis | 8 weeks | Term | |||
| Pulmonary atresia | |||||
| With VSD | 6 weeks | 8 weeks | |||
| With intact ventricular septum | 8 weeks | Term | |||
| Other | |||||
| Functionally single ventricle | 5 weeks | 6 weeks | |||
| Tetralogy of Fallot | 7 weeks | 8 weeks | |||
| Totally anomalous pulmonary venous return | 8 weeks | 12 weeks | |||
| Tricuspid atresia | 5 weeks | 6 weeks | |||
| Common arterial trunk | 5 weeks | 7 weeks | |||
| Bicuspid aortic valve | 6 weeks | Term | |||
| Notes | |||||
| For approximate clinical Gestational Age GA add 2 weeks; number in brackets is mouse equivalent. Data Reference[1] | Links: heart | abnormal development | timeline | Category:Timeline | ||||
| Table 2. Summary of Timing (Post Fertilization) of Cardiac Susceptibility to a Drug-Induced Malformation | ||
|---|---|---|
| Lesion | Start of Susceptibility to Malformation |
End of Susceptibility to Malformation |
| Interatrial communications | ||
| Oval fossa defect | 6 weeks (E13.5) | Term |
| Sinus venosus defect | 8 weeks | 12 weeks |
| Coronary sinus defect | 8 weeks | Term |
| Vestibular defect | 7 weeks | 8 weeks |
| Ventricular Septal Defect | ||
| Muscular | 8 weeks | Difficult to predict |
| Perimembranous | 6 weeks | 8 weeks |
| Doubly committed | 7 weeks | 8 weeks |
| Atrioventricular Septal Defect | ||
| Ostium primum | 5 weeks | 6 weeks |
| “Complete” | 5 weeks | 6 weeks |
| Aortic coarctation | ||
| With VSD | 5 weeks | 8 weeks |
| With intact ventricular septum | 8 weeks | Term |
| Double Outlet Right Ventricle | 6 weeks | 8 weeks |
| Transposition of Great Arteries | 6 weeks | 8 weeks |
| Ebstein’s malformation | 6 weeks | 8 weeks |
| Hypoplastic left heart syndrome | ||
| With mitral atresia | 5 weeks | 8 weeks |
| With mitral stenosis | 8 weeks | Term |
| Pulmonary atresia | ||
| With VSD | 6 weeks | 8 weeks |
| With intact ventricular septum | 8 weeks | Term |
| Other | ||
| Functionally single ventricle | 5 weeks | 6 weeks |
| Tetralogy of Fallot | 7 weeks | 8 weeks |
| Totally anomalous pulmonary venous return | 8 weeks | 12 weeks |
| Tricuspid atresia | 5 weeks | 6 weeks |
| Common arterial trunk | 5 weeks | 7 weeks |
| Bicuspid aortic valve | 6 weeks | Term |
|
Notes: For approximate clinical Gestational Age GA add 2 weeks; number in brackets is mouse equivalent. Reference: Anderson RH. Teratogenecity in the setting of cardiac development and maldevelopment. (2016) | ||